MyFinsight
Home
Blog
About
something is missing
$75,001K
Proceeds from sales and
maturities of investments
$38,000K
(-62.00%↓ Y/Y)
Cash received for
sale of business
$24,992K
Proceeds from sales of
equity investments
$3,090K
Net cash provided by
investing activities
$14,408K
(-65.80%↓ Y/Y)
Effect of foreign
exchange rate...
$294K
(-74.32%↓ Y/Y)
Canceled cashflow
$126,675K
Net increase
(decrease) in cash, cash...
$4,253K
(155.86%↑ Y/Y)
Canceled cashflow
$10,449K
Purchases of long-term
investments
$90,362K
Purchases of short-term
investments
$35,967K
(-29.38%↓ Y/Y)
Purchases of property and
equipment
$344K
(-95.04%↓ Y/Y)
Purchases of marketable
equity securities
$2K
Accrued liabilities
$6,645K
(347.47%↑ Y/Y)
Indemnification-related loss
-$4,212K
Stock-based compensation
expense
$4,050K
(-73.69%↓ Y/Y)
Accounts payable
$1,665K
(98.69%↑ Y/Y)
Depreciation and
amortization
$1,273K
(-80.26%↓ Y/Y)
Inventory
-$1,249K
(-114.61%↓ Y/Y)
Accounts receivable, net
-$1,248K
(-154.33%↓ Y/Y)
Non-cash lease expense
$1,245K
(-56.54%↓ Y/Y)
Provision for excess and
obsolete inventory
$1,074K
(-21.03%↓ Y/Y)
Deferred tax asset,
non-current
$5K
Proceeds from espp stock
issuance
$120K
(-61.04%↓ Y/Y)
Net cash used in
operating activities
-$10,311K
(79.76%↑ Y/Y)
Net cash (used in)
provided by financing...
-$138K
(-322.58%↓ Y/Y)
Canceled cashflow
$22,666K
Canceled cashflow
$120K
Net income (loss)
-$26,758K
(55.02%↑ Y/Y)
Payments for taxes
related to net share...
$258K
(4.88%↑ Y/Y)
Operating lease
liabilities
-$1,344K
(56.15%↑ Y/Y)
Accretion of discount on
investments, net
$1,207K
(-23.17%↓ Y/Y)
Realized gain on equity
investments
$1,187K
Prepaid expenses and
other assets
$1,041K
(-11.40%↓ Y/Y)
Unrealized loss on equity
investments
$952K
Deferred revenue
-$460K
(75.79%↑ Y/Y)
Other non-cash items
-$21K
(-104.40%↓ Y/Y)
Other liabilities
-$7K
(-104.90%↓ Y/Y)
Back
Back
Cash Flow
STANDARD BIOTOOLS INC. (LAB)
STANDARD BIOTOOLS INC. (LAB)
source: myfinsight.com